freseniuskabiscience.com freseniuskabiscience.com

freseniuskabiscience.com

Home - Fresenius Kabi: Scientific Investigator Award

Scientific Investigator Award Fresenius Kabi is proud to support scientific and clinical research that advances transfusion medicine, therapeutic apheresis and cellular therapies. This year’s award will focus on the areas of photopheresis and red cell exchange. Fresenius Kabi will provide up to $100,000 in research funds to the winning applicant(s). The deadline for application has …

http://www.freseniuskabiscience.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR FRESENIUSKABISCIENCE.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

January

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.3 out of 5 with 8 reviews
5 star
3
4 star
0
3 star
3
2 star
0
1 star
2

Hey there! Start your review of freseniuskabiscience.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.9 seconds

CONTACTS AT FRESENIUSKABISCIENCE.COM

Anthony Krzysko

220 N●●●●●th St

Sui●●●204

Pal●●●ine , Illinois, 60067

UNITED STATES

847●●●008
ad●●●●●●●●●●●@exclaim-inc.com

View this contact

Anthony Krzysko

220 N●●●●●th St

Sui●●●204

Pal●●●ine , Illinois, 60067

UNITED STATES

847●●●008
ad●●●●●●●●●●●@exclaim-inc.com

View this contact

Anthony Krzysko

220 N●●●●●th St

Sui●●●204

Pal●●●ine , Illinois, 60067

UNITED STATES

847●●●008
ad●●●●●●●●●●●@exclaim-inc.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2013 November 05
UPDATED
2013 November 05
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 10

    YEARS

  • 6

    MONTHS

  • 11

    DAYS

NAME SERVERS

1
ns73.domaincontrol.com
2
ns74.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

SCORE

6.2

PAGE TITLE
Home - Fresenius Kabi: Scientific Investigator Award | freseniuskabiscience.com Reviews
<META>
DESCRIPTION
Scientific Investigator Award Fresenius Kabi is proud to support scientific and clinical research that advances transfusion medicine, therapeutic apheresis and cellular therapies. This year’s award will focus on the areas of photopheresis and red cell exchange. Fresenius Kabi will provide up to $100,000 in research funds to the winning applicant(s). The deadline for application has &hellip;
<META>
KEYWORDS
1 scientific investigator award
2 the award
3 about us
4 select menu
5 apply now
6 press release
7 legal disclaimer
8 imprint
9 fresenius kabi com
10 fresenius kabi us
CONTENT
Page content here
KEYWORDS ON
PAGE
scientific investigator award,the award,about us,select menu,apply now,press release,legal disclaimer,imprint,fresenius kabi com,fresenius kabi us
SERVER
Apache/2.2.29 (Unix) mod_ssl/2.2.29 OpenSSL/1.0.1e-fips mod_bwlimited/1.4
POWERED BY
PHP/5.4.42
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Home - Fresenius Kabi: Scientific Investigator Award | freseniuskabiscience.com Reviews

https://freseniuskabiscience.com

Scientific Investigator Award Fresenius Kabi is proud to support scientific and clinical research that advances transfusion medicine, therapeutic apheresis and cellular therapies. This year’s award will focus on the areas of photopheresis and red cell exchange. Fresenius Kabi will provide up to $100,000 in research funds to the winning applicant(s). The deadline for application has &hellip;

INTERNAL PAGES

freseniuskabiscience.com freseniuskabiscience.com
1

The Award - Fresenius Kabi: Scientific Investigator Award

http://freseniuskabiscience.com/the-award

Fresenius Kabi is proud to support scientific and clinical research that advances transfusion medicine, therapeutic apheresis and cellular therapies. The 2013 award program will support research and exploration to further the understanding in two therapeutics areas: photopheresis and red cell exchange. Award funds will be disbursed between late December, 2013 and January, 2014. Funds can be used to cover direct costs, salary and overhead associated with the approved proposal.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

1

OTHER SITES

freseniuskabi.mobi freseniuskabi.mobi

This domain has no active presence

Sorry for any inconvenience. This domain has no active presence.

freseniuskabi.net freseniuskabi.net

This domain has no active presence

Sorry for any inconvenience. This domain has no active presence.

freseniuskabi.us freseniuskabi.us

This domain has no active presence

Sorry for any inconvenience. This domain has no active presence.

freseniuskabimanufacturing.com freseniuskabimanufacturing.com

Soon to be the new home of: www.freseniuskabimanufacturing.com

Soon to be the new home of.

freseniuskabiresearch.com freseniuskabiresearch.com

Home - Fresenius Kabi: Scientific Investigator Award

Receive up to $100,000 in funds for your research in the areas of photopheresis and red cell exchange. Fresenius Kabi is proud to support scientific and clinical research that advances transfusion medicine, therapeutic apheresis and cellular therapies. This year’s award will focus on the areas of photopheresis and red cell exchange. Fresenius Kabi will provide up to $100,000 in research funds to the winning applicant(s). The deadline for application has passed.

freseniuskabiscience.com freseniuskabiscience.com

Home - Fresenius Kabi: Scientific Investigator Award

Receive up to $100,000 in funds for your research in the areas of photopheresis and red cell exchange. Fresenius Kabi is proud to support scientific and clinical research that advances transfusion medicine, therapeutic apheresis and cellular therapies. This year’s award will focus on the areas of photopheresis and red cell exchange. Fresenius Kabi will provide up to $100,000 in research funds to the winning applicant(s). The deadline for application has passed.

freseniuskidneycare.com freseniuskidneycare.com

Chronic Kidney Disease and Dialysis Treatment | Fresenius Kidney Care

Skip to main content. Find a Dialysis Center. Find a Dialysis Center (City, State or ZIP). Find a Dialysis Center. Permission to detect location was denied. Current location could not be determined. Use My Current Location. Understanding Chronic Kidney Disease. Who´s at Risk. Take a Treatment Options Class. Tips for Loved Ones. My Fresenius Kidney Care Portal. Chef Aaron McCargo, Jr.s Best Advice. I Have Kidney Disease. Find a Dialysis Center. Permission to detect location was denied. Who´s at Risk.

freseniuslawsuits.com freseniuslawsuits.com

Freseniuslawsuits.com

This domain may be for sale. Backorder this Domain. This Domain Name Has Expired - Renewal Instructions.

freseniusmedical.com freseniusmedical.com

Search Results for "freseniusmedical.com"

Click here to proceed.

freseniusmedicalcare.asia freseniusmedicalcare.asia

Healthcare | Renal | Dialysis - Fresenius Medical Care

Patients and Families overview. Living with chronic kidney disease. Services from Fresenius Medical Care. Stay safe and Biofine. CRRT and plasmapheresis filters. Services and resources overview. Therapy Data Management System (TDMS). Therapy Support Suite (TSS). Communication Data Link (cDL). Click the menu button to access any page. We care about kidneys. Explore our service for patients and families. Learn about our products and therapies. Services from Fresenius Medical Care. March 5, 2015.

freseniusmedicalcare.com freseniusmedicalcare.com

Healthcare | Renal | Dialysis - Fresenius Medical Care

Fresenius Medical Care uses cookies on this website to enhance the user experience and provide the best possible service. By continuing to browse the website, you consent to our use of cookies. For details see our privacy policy. Patients and Families overview. Living with chronic kidney disease. Services from Fresenius Medical Care. 5008 CorDiax and 5008S CorDiax. Stay safe and Biofine. CRRT and plasmapheresis filters. Therapy Data Management System (TDMS). Therapy Support Suite (TSS). February 27, 2018.